Toxicological Effects of Veterinary Medicinal Products in Humans

Since 1984 Dr. Kevin Woodward's experience has been centred on all aspects of the evaluation and regulation of veterinary drugs, particularly from the point of view of safety evaluation, toxicology, user risk assessment and pharmacovigilance. He was a member of the Committee for Veterinary Medicinal Products (CVMP) until August 1996 and Chairman of its Safety of Residues Working Group from 1991 until 1996. He was a member of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) and an invited expert to the Committee for the years 1988-1996. He has also been leader of the UK delegation to the Codex Committee on Residues of Veterinary Drugs in Food from 1993 to 1996. From September 1997 until September 1999, and again from 1999 until November 2001, he chaired IFAH-Europe's (formerly FEDESA's) Technical and Regulatory Committee and was elected to the Board of Directors of FEDESA in February 2002 and to the Board of Directors of NOAH (ex-officio), also in February 2002. Since 2008, he has been the Regulatory Officer for the EAVPT.

Volume 1;

Occupational Health and Safety Among Veterinarians and Veterinary Workers;

Regulation of Veterinary Medicines;

Consumer Safety - Maximum Residue Limits;

The assessment of user safety;

General Anaesthetics;

Veterinary products containing pesticide active ingredients;

Antineoplastic drugs;

Anti-microbial drugs;

Subject Index;

Volume 2;

Human safety of coccidiostats: A European perspective;

Organophosphorus veterinary medicines;

Antifungal drugs;

Antiparasitic drugs;

Some other pharmacologically active drugs;

Human safety of veterinary vaccines;

Adverse drug reactions in humans - Data from veterinary pharmacovigilance schemes;

Veterinary medicines and the environment;

Potential adverse microbiological effects of antimicrobials;

subject index